 | • レポートコード：MRC2312MG09062 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のミルベキシム駆虫薬市場規模と予測を収録しています。・世界のミルベキシム駆虫薬市場：売上、2018年-2023年、2024年-2029年 ・世界のミルベキシム駆虫薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のミルベキシム駆虫薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「単一成分」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ミルベキシム駆虫薬のグローバル主要企業は、Elanco Animal Health、 Boehringer Ingelheim Animal Health、 Merck Animal Health、 VIRBAC SA、 Krka、 Zhejiang Hisun Pharmaceutical Co., Ltdなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ミルベキシム駆虫薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のミルベキシム駆虫薬市場：タイプ別、2018年-2023年、2024年-2029年 世界のミルベキシム駆虫薬市場：タイプ別市場シェア、2022年 ・単一成分、複合成分 世界のミルベキシム駆虫薬市場：用途別、2018年-2023年、2024年-2029年 世界のミルベキシム駆虫薬市場：用途別市場シェア、2022年 ・猫、犬、その他 世界のミルベキシム駆虫薬市場：地域・国別、2018年-2023年、2024年-2029年 世界のミルベキシム駆虫薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるミルベキシム駆虫薬のグローバル売上、2018年-2023年 ・主要企業におけるミルベキシム駆虫薬のグローバル売上シェア、2022年 ・主要企業におけるミルベキシム駆虫薬のグローバル販売量、2018年-2023年 ・主要企業におけるミルベキシム駆虫薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Elanco Animal Health、 Boehringer Ingelheim Animal Health、 Merck Animal Health、 VIRBAC SA、 Krka、 Zhejiang Hisun Pharmaceutical Co., Ltd ************************************************************* ・調査・分析レポートの概要 ミルベキシム駆虫薬市場の定義 市場セグメント 世界のミルベキシム駆虫薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のミルベキシム駆虫薬市場規模 世界のミルベキシム駆虫薬市場規模：2022年 VS 2029年 世界のミルベキシム駆虫薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのミルベキシム駆虫薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のミルベキシム駆虫薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：単一成分、複合成分 ミルベキシム駆虫薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：猫、犬、その他 ミルベキシム駆虫薬の用途別グローバル売上・予測 ・地域別市場分析 地域別ミルベキシム駆虫薬市場規模 2022年と2029年 地域別ミルベキシム駆虫薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Elanco Animal Health、 Boehringer Ingelheim Animal Health、 Merck Animal Health、 VIRBAC SA、 Krka、 Zhejiang Hisun Pharmaceutical Co., Ltd ... |
This research report provides a comprehensive analysis of the Milbexime Anthelmintic market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Milbexime Anthelmintic market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Milbexime Anthelmintic, challenges faced by the industry, and potential opportunities for market players.
The global Milbexime Anthelmintic market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Milbexime Anthelmintic market presents opportunities for various stakeholders, including Cat, Dog. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Milbexime Anthelmintic market. Additionally, the growing consumer demand present avenues for market expansion.
The global Milbexime Anthelmintic market was valued at US$ 592.3 million in 2022 and is projected to reach US$ 900.4 million by 2029, at a CAGR of 6.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Milbexime Anthelmintic market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Milbexime Anthelmintic market.
Market Overview: The report provides a comprehensive overview of the Milbexime Anthelmintic market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Single Ingredient, Compound Ingredients), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Milbexime Anthelmintic market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Milbexime Anthelmintic market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Milbexime Anthelmintic market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Milbexime Anthelmintic market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Milbexime Anthelmintic market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Milbexime Anthelmintic market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Milbexime Anthelmintic, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Milbexime Anthelmintic market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Milbexime Anthelmintic market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Single Ingredient
Compound Ingredients
Market segment by Application
Cat
Dog
Other
Global Milbexime Anthelmintic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
VIRBAC SA
Krka
Zhejiang Hisun Pharmaceutical Co., Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Milbexime Anthelmintic, market overview.
Chapter 2: Global Milbexime Anthelmintic market size in revenue and volume.
Chapter 3: Detailed analysis of Milbexime Anthelmintic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Milbexime Anthelmintic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Milbexime Anthelmintic capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Milbexime Anthelmintic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Milbexime Anthelmintic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Milbexime Anthelmintic Overall Market Size
2.1 Global Milbexime Anthelmintic Market Size: 2022 VS 2029
2.2 Global Milbexime Anthelmintic Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Milbexime Anthelmintic Sales: 2018-2029
3 Company Landscape
3.1 Top Milbexime Anthelmintic Players in Global Market
3.2 Top Global Milbexime Anthelmintic Companies Ranked by Revenue
3.3 Global Milbexime Anthelmintic Revenue by Companies
3.4 Global Milbexime Anthelmintic Sales by Companies
3.5 Global Milbexime Anthelmintic Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Milbexime Anthelmintic Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Milbexime Anthelmintic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Milbexime Anthelmintic Players in Global Market
3.8.1 List of Global Tier 1 Milbexime Anthelmintic Companies
3.8.2 List of Global Tier 2 and Tier 3 Milbexime Anthelmintic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Milbexime Anthelmintic Market Size Markets, 2022 & 2029
4.1.2 Single Ingredient
4.1.3 Compound Ingredients
4.2 By Type – Global Milbexime Anthelmintic Revenue & Forecasts
4.2.1 By Type – Global Milbexime Anthelmintic Revenue, 2018-2023
4.2.2 By Type – Global Milbexime Anthelmintic Revenue, 2024-2029
4.2.3 By Type – Global Milbexime Anthelmintic Revenue Market Share, 2018-2029
4.3 By Type – Global Milbexime Anthelmintic Sales & Forecasts
4.3.1 By Type – Global Milbexime Anthelmintic Sales, 2018-2023
4.3.2 By Type – Global Milbexime Anthelmintic Sales, 2024-2029
4.3.3 By Type – Global Milbexime Anthelmintic Sales Market Share, 2018-2029
4.4 By Type – Global Milbexime Anthelmintic Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Milbexime Anthelmintic Market Size, 2022 & 2029
5.1.2 Cat
5.1.3 Dog
5.1.4 Other
5.2 By Application – Global Milbexime Anthelmintic Revenue & Forecasts
5.2.1 By Application – Global Milbexime Anthelmintic Revenue, 2018-2023
5.2.2 By Application – Global Milbexime Anthelmintic Revenue, 2024-2029
5.2.3 By Application – Global Milbexime Anthelmintic Revenue Market Share, 2018-2029
5.3 By Application – Global Milbexime Anthelmintic Sales & Forecasts
5.3.1 By Application – Global Milbexime Anthelmintic Sales, 2018-2023
5.3.2 By Application – Global Milbexime Anthelmintic Sales, 2024-2029
5.3.3 By Application – Global Milbexime Anthelmintic Sales Market Share, 2018-2029
5.4 By Application – Global Milbexime Anthelmintic Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Milbexime Anthelmintic Market Size, 2022 & 2029
6.2 By Region – Global Milbexime Anthelmintic Revenue & Forecasts
6.2.1 By Region – Global Milbexime Anthelmintic Revenue, 2018-2023
6.2.2 By Region – Global Milbexime Anthelmintic Revenue, 2024-2029
6.2.3 By Region – Global Milbexime Anthelmintic Revenue Market Share, 2018-2029
6.3 By Region – Global Milbexime Anthelmintic Sales & Forecasts
6.3.1 By Region – Global Milbexime Anthelmintic Sales, 2018-2023
6.3.2 By Region – Global Milbexime Anthelmintic Sales, 2024-2029
6.3.3 By Region – Global Milbexime Anthelmintic Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Milbexime Anthelmintic Revenue, 2018-2029
6.4.2 By Country – North America Milbexime Anthelmintic Sales, 2018-2029
6.4.3 US Milbexime Anthelmintic Market Size, 2018-2029
6.4.4 Canada Milbexime Anthelmintic Market Size, 2018-2029
6.4.5 Mexico Milbexime Anthelmintic Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Milbexime Anthelmintic Revenue, 2018-2029
6.5.2 By Country – Europe Milbexime Anthelmintic Sales, 2018-2029
6.5.3 Germany Milbexime Anthelmintic Market Size, 2018-2029
6.5.4 France Milbexime Anthelmintic Market Size, 2018-2029
6.5.5 U.K. Milbexime Anthelmintic Market Size, 2018-2029
6.5.6 Italy Milbexime Anthelmintic Market Size, 2018-2029
6.5.7 Russia Milbexime Anthelmintic Market Size, 2018-2029
6.5.8 Nordic Countries Milbexime Anthelmintic Market Size, 2018-2029
6.5.9 Benelux Milbexime Anthelmintic Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Milbexime Anthelmintic Revenue, 2018-2029
6.6.2 By Region – Asia Milbexime Anthelmintic Sales, 2018-2029
6.6.3 China Milbexime Anthelmintic Market Size, 2018-2029
6.6.4 Japan Milbexime Anthelmintic Market Size, 2018-2029
6.6.5 South Korea Milbexime Anthelmintic Market Size, 2018-2029
6.6.6 Southeast Asia Milbexime Anthelmintic Market Size, 2018-2029
6.6.7 India Milbexime Anthelmintic Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Milbexime Anthelmintic Revenue, 2018-2029
6.7.2 By Country – South America Milbexime Anthelmintic Sales, 2018-2029
6.7.3 Brazil Milbexime Anthelmintic Market Size, 2018-2029
6.7.4 Argentina Milbexime Anthelmintic Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Milbexime Anthelmintic Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Milbexime Anthelmintic Sales, 2018-2029
6.8.3 Turkey Milbexime Anthelmintic Market Size, 2018-2029
6.8.4 Israel Milbexime Anthelmintic Market Size, 2018-2029
6.8.5 Saudi Arabia Milbexime Anthelmintic Market Size, 2018-2029
6.8.6 UAE Milbexime Anthelmintic Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Elanco Animal Health
7.1.1 Elanco Animal Health Company Summary
7.1.2 Elanco Animal Health Business Overview
7.1.3 Elanco Animal Health Milbexime Anthelmintic Major Product Offerings
7.1.4 Elanco Animal Health Milbexime Anthelmintic Sales and Revenue in Global (2018-2023)
7.1.5 Elanco Animal Health Key News & Latest Developments
7.2 Boehringer Ingelheim Animal Health
7.2.1 Boehringer Ingelheim Animal Health Company Summary
7.2.2 Boehringer Ingelheim Animal Health Business Overview
7.2.3 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Major Product Offerings
7.2.4 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales and Revenue in Global (2018-2023)
7.2.5 Boehringer Ingelheim Animal Health Key News & Latest Developments
7.3 Merck Animal Health
7.3.1 Merck Animal Health Company Summary
7.3.2 Merck Animal Health Business Overview
7.3.3 Merck Animal Health Milbexime Anthelmintic Major Product Offerings
7.3.4 Merck Animal Health Milbexime Anthelmintic Sales and Revenue in Global (2018-2023)
7.3.5 Merck Animal Health Key News & Latest Developments
7.4 VIRBAC SA
7.4.1 VIRBAC SA Company Summary
7.4.2 VIRBAC SA Business Overview
7.4.3 VIRBAC SA Milbexime Anthelmintic Major Product Offerings
7.4.4 VIRBAC SA Milbexime Anthelmintic Sales and Revenue in Global (2018-2023)
7.4.5 VIRBAC SA Key News & Latest Developments
7.5 Krka
7.5.1 Krka Company Summary
7.5.2 Krka Business Overview
7.5.3 Krka Milbexime Anthelmintic Major Product Offerings
7.5.4 Krka Milbexime Anthelmintic Sales and Revenue in Global (2018-2023)
7.5.5 Krka Key News & Latest Developments
7.6 Zhejiang Hisun Pharmaceutical Co., Ltd
7.6.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Summary
7.6.2 Zhejiang Hisun Pharmaceutical Co., Ltd Business Overview
7.6.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Major Product Offerings
7.6.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales and Revenue in Global (2018-2023)
7.6.5 Zhejiang Hisun Pharmaceutical Co., Ltd Key News & Latest Developments
8 Global Milbexime Anthelmintic Production Capacity, Analysis
8.1 Global Milbexime Anthelmintic Production Capacity, 2018-2029
8.2 Milbexime Anthelmintic Production Capacity of Key Manufacturers in Global Market
8.3 Global Milbexime Anthelmintic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Milbexime Anthelmintic Supply Chain Analysis
10.1 Milbexime Anthelmintic Industry Value Chain
10.2 Milbexime Anthelmintic Upstream Market
10.3 Milbexime Anthelmintic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Milbexime Anthelmintic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer